ArticleDermatology practical & conceptual2022
Fractional Carbon Dioxide (CO
Article in Dermatology practical & conceptual, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 7 citations in OpenAlex.
- Energy-based devices for enhanced transdermal drug delivery in pathological scars: A review.Lasers in medical science · 2026Review
- Pharmacotherapy for Keloids and Hypertrophic Scars.International journal of molecular sciences · 2024Review
- Revisiting roles of mast cells and neural cells in keloid: exploring their connection to disease activity.Frontiers in immunology · 2024Article
- Hypertrophic Scars and Keloids: Advances in Treatment and Review of Established Therapies.American journal of clinical dermatology · 2023Review
- Clinical Features and the Outcome Evaluations of Keloid and Hypertrophic Scar Treatment with Triamcinolone Injection in Mekong Delta, Vietnam - A Cross-Sectional Study.Clinical, cosmetic and investigational dermatology · 2023Article
- A Randomized Study to Evaluate the Efficacy and Adverse Effects of Cryotherapy Combined with Intralesional Steroids, Intralesional Bleomycin Combined with Steroids and Fractional COIndian dermatology online journalArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Keloids are benign fibro-proliferative scarring extending outside the initial wound. Different treatment modalities as intralesional corticosteroid injection, fractional CO Objectives: To assess the efficacy of fractional CO Methods: The current study was conducted on 45 Egyptian participants with keloid scars at different sites of the body. They were classified into 3 groups treated by fractional CO Results: After treatment, there was a high statistically significant reduction in VSS among the 3 groups (P ≤ 0.001); the reduction was more in group II than in I and III. Also, a high statistically significant reduction in keloid scar thickness assessed by CDU was recorded (P ≤0.001 in group II and P ≤0.01 in group I and III). Conclusions: Combined therapy is favorable in the treatment of keloids. Trichloroacetic acid is a promising modality in treating keloid, hence it can be tried in different combinations. CDU is a promising method of keloids pre-and post-treatment assessment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.